GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Spring Pharmaceutical Group Inc (OTCPK:CYIG) » Definitions » Net Margin %

Spring Pharmaceutical Group (Spring Pharmaceutical Group) Net Margin % : 9.12% (As of Mar. 2019)


View and export this data going back to . Start your Free Trial

What is Spring Pharmaceutical Group Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Spring Pharmaceutical Group's Net Income for the three months ended in Mar. 2019 was $0.98 Mil. Spring Pharmaceutical Group's Revenue for the three months ended in Mar. 2019 was $10.72 Mil. Therefore, Spring Pharmaceutical Group's net margin for the quarter that ended in Mar. 2019 was 9.12%.

The historical rank and industry rank for Spring Pharmaceutical Group's Net Margin % or its related term are showing as below:


CYIG's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.76
* Ranked among companies with meaningful Net Margin % only.

Spring Pharmaceutical Group Net Margin % Historical Data

The historical data trend for Spring Pharmaceutical Group's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spring Pharmaceutical Group Net Margin % Chart

Spring Pharmaceutical Group Annual Data
Trend Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.43 17.60 17.85 17.53 19.90

Spring Pharmaceutical Group Quarterly Data
Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.33 21.48 21.84 22.27 9.12

Competitive Comparison of Spring Pharmaceutical Group's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Spring Pharmaceutical Group's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spring Pharmaceutical Group's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Spring Pharmaceutical Group's Net Margin % distribution charts can be found below:

* The bar in red indicates where Spring Pharmaceutical Group's Net Margin % falls into.



Spring Pharmaceutical Group Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Spring Pharmaceutical Group's Net Margin for the fiscal year that ended in Mar. 2019 is calculated as

Net Margin=Net Income (A: Mar. 2019 )/Revenue (A: Mar. 2019 )
=13.887/69.793
=19.90 %

Spring Pharmaceutical Group's Net Margin for the quarter that ended in Mar. 2019 is calculated as

Net Margin=Net Income (Q: Mar. 2019 )/Revenue (Q: Mar. 2019 )
=0.978/10.724
=9.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Spring Pharmaceutical Group  (OTCPK:CYIG) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Spring Pharmaceutical Group Net Margin % Related Terms

Thank you for viewing the detailed overview of Spring Pharmaceutical Group's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Spring Pharmaceutical Group (Spring Pharmaceutical Group) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Quanxing Road, Sishui County, Shandong Province, Jinan, CHN, 273200
Spring Pharmaceutical Group Inc is a health care company. The company is engaged in the developing, manufacturing and selling innovative traditional Chinese medicines made from panax ginseng leaves extract, developing acer truncatum bunge planting, processing and selling acer truncatum bunge seed oils in the PRC. Some of its product includes Vitality Source Capsule (24 capsules); Vitality Source Capsules (36 capsules); Millet cattle drinking music and others.